RPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19
April 03, 2020 at 02:39 AM EDT
Novartis and Incyte plan to test their drug Jakavi in patients with coronavirus-caused COVID-19, joining other firms including Roche and Sanofi hoping to repurpose older medicines to help critically ill patients.